On Monday, September 12, another meeting of the Transparency Council.
The Ministry of Health has already received ten parliamentary interpellations on the eligibility criteria for SMA treatment with gene therapy. The Ministry of Health has already responded to the first parliamentary interventions, but there are more.
We ask Prof. Marcin Grabowski, head of the 1st Department and Clinic of Cardiology of the Medical University of Warsaw.
Organizations of drug manufacturers, wholesalers and pharmacists asked Prime Minister Mateusz Morawiecki not to proceed with the draft amendment to the Reimbursement Act as proposed by the Ministry of Health and to urgently start work on provisions related to ensuring drug safety and the...
On Monday, September 5, another meeting of the Transparency Council.
The agenda is: Preparation of a position on the legitimacy of granting consent for the reimbursement of Renastep food for particular nutritional uses in the indication: chronic renal failure in the pediatric population. Preparation of an opinion on the draft health policy program of local...
In Journal of Laws The Ministry of Health published the Notice of the Minister of Health of August 22, 2022 on the list of reimbursed drugs, foodstuffs for particular nutritional uses and medical devices on September 1, 2022.
On the website of the Ministry of Health, a Draft announcement of the Minister of Health on the list of reimbursed drugs, foodstuffs for particular nutritional uses and medical devices has been published, which will enter into force on September 1, 2022. Comments to the draft Notice of the...
In Poland, the statutory margin for reimbursed drugs, which is too low, has not been changed for over ten years. The current wholesale costs - inflation, rising fuel prices, electricity and other expenses related to the storage and delivery of drugs - have become a challenge for the entire...
On Tuesday, August 16, there will be another meeting of the Transparency Council.
Wholesalers are alarming that the rapidly growing distribution costs threaten the possibility of continuing to supply pharmacies and hospitals in the current shape. The patient will have to wait patiently for medications.
On September 1 (Monday) another meeting of the Transparency Council.
We talk to prof. Grażyna Rydzewska, vice-president of the Polish Society of Gastroenterology and Marek Lichota, president of the association "Appetite for life".
The agenda includes: Preparation of an opinion on the validity of changes to the drug program B.61 "Treatment of patients with early childhood nephropathic cystinosis (ICD-10: E 72.0)". Preparation of opinions on draft health policy programs of local government units: • "Breast cancer prevention...
In line with the guidelines of the European Commission on the European plan to reduce gas demand, Medicines for Europe - an organization associating European pharmaceutical companies, which also includes National Drug Manufacturers (PZPPF), calls on the governments of EU countries to maintain...
Two new representatives of the National Health Fund joined the Economic Commission: Piotr Włodarczyk and Wojciech Modzelewski. • Chairman of the Economic Committee: prof. Mirosław Szeligowski • Deputy Chairman of the Economic Committee: Joanna Kilkowska • Secretary of the Economic Committee:...
The first clinic in Poland introduces an innovative method of ultrafast diagnosis of skin diseases.
July 14 this year During the meeting of the Committee on Petitions of the European Parliament in Brussels, Grzegorz Rychwalski, vice-president of Polish Medicines Manufacturers, emphasized that Europeans are not safe today, because 80% of the substances used in the production of drugs used in the...
Folded in May this year. by National Medicines Manufacturers to the European Parliament "Petition on the need to support the production of active substances for medicinal products in the EU territory" will be considered on July 14 this year. around 9.30 by the EP Petitions Committee.
Eisai and Biogen announced that the US Food and Drug Administration (FDA) will process as a matter of priority an application for the marketing of lecanemab, an anti-beta-amyloid antibody. The Agency has indicated 6 January next year as the target date for the publication of the decision. The...
The French drug manufacturer Sanofi wants to have a real impact on changes in the availability of therapy in low-income countries. And the word "impact" can be clearly emphasized here, because the distribution of drugs in a non-profit mode will be handled by a new brand: Impact.
July 11, meeting of the Transparency Council.
Novavax announced that NVX-CoV2373 COVID-19 vaccine has been recommended for Extended Conditional Marketing Authorization (CMA) in the European Union (EU) for adolescents 12-17 years of age. The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency based its...
In Journal of Laws The Ministry of Health published an Notice of the Minister of Health of 27 June 2022 on the list of medicinal products, foodstuffs for particular nutritional uses and medical devices at risk of unavailability in the territory of the Republic of Poland.
The US Food and Drug Administration (FDA) has approved a 15-valent pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease in infants and children.
On the website of the Ministry of Health, a Draft announcement of the Minister of Health on the list of reimbursed drugs, foodstuffs for particular nutritional uses and medical devices has been published, which will enter into force on July 1, 2022. Comments to the draft Notice of the Minister of...
The next meeting of the Transparency Council will take place on June 20.
Five scientific abstracts on Vertex's cystic fibrosis drugs were presented at the 45th Conference of the European Cystic Fibrosis Society (ECFS) held in Rotterdam, the Netherlands, on June 8-11, 2022. The presented analysis of data collected in the US CF Foundation Patient Registry CFFPR covering...
The next meeting of the Transparency Council will be held on June 13 (Monday).
TZF Polfa S.A. joined the group of members of PASMI - Employers' Union "Polish Union of Drug Manufacturers Without Prescription".
© 2023 Medexpress. All Rights Reserved
